1. Home
  2. CABR vs MBAI Comparison

CABR vs MBAI Comparison

Compare CABR & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CABR

Caring Brands Inc.

N/A

Current Price

$1.16

Market Cap

13.9M

ML Signal

N/A

Logo Check-Cap Ltd. Ordinary Share

MBAI

Check-Cap Ltd. Ordinary Share

N/A

Current Price

$1.75

Market Cap

12.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CABR
MBAI
Founded
2020
2004
Country
United States
Israel
Employees
N/A
85
Industry
Package Goods/Cosmetics
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
13.9M
12.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CABR
MBAI
Price
$1.16
$1.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
98.7K
72.9K
Earning Date
03-20-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$1.31
52 Week High
$1.65
$3.92

Technical Indicators

Market Signals
Indicator
CABR
MBAI
Relative Strength Index (RSI) 57.95 54.00
Support Level $0.78 $1.38
Resistance Level $1.36 $1.89
Average True Range (ATR) 0.15 0.19
MACD 0.00 0.01
Stochastic Oscillator 67.81 40.85

Price Performance

Historical Comparison
CABR
MBAI

About CABR Caring Brands Inc.

Caring Brands Inc is a consumer wellness company that supports health and wellness through research and development. Its product pipeline addresses a range of conditions, including hair loss, eczema, burns, and sexual wellness. The majority of revenue is generated from the sale of OTC and consumer products, as well as licensing royalties.

About MBAI Check-Cap Ltd. Ordinary Share

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: